Aurora Cannabis Inc (ACB)
6.74
-0.23
(-3.30%)
USD |
NASDAQ |
May 03, 16:00
6.70
-0.04
(-0.59%)
After-Hours: 20:00
Aurora Cannabis Enterprise Value: 328.45M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 328.45M |
May 02, 2024 | 340.99M |
May 01, 2024 | 362.26M |
April 30, 2024 | 464.25M |
April 29, 2024 | 305.54M |
April 26, 2024 | 326.27M |
April 25, 2024 | 326.81M |
April 24, 2024 | 353.54M |
April 23, 2024 | 365.54M |
April 22, 2024 | 303.36M |
April 19, 2024 | 313.18M |
April 18, 2024 | 317.27M |
April 17, 2024 | 276.64M |
April 16, 2024 | 282.64M |
April 15, 2024 | 303.36M |
April 12, 2024 | 320.81M |
April 11, 2024 | 333.36M |
April 10, 2024 | 329.54M |
April 09, 2024 | 307.45M |
April 08, 2024 | 343.17M |
April 05, 2024 | 322.45M |
April 04, 2024 | 345.90M |
April 03, 2024 | 354.08M |
April 02, 2024 | 233.82M |
April 01, 2024 | 195.92M |
Date | Value |
---|---|
March 28, 2024 | 200.28M |
March 27, 2024 | 219.92M |
March 26, 2024 | 190.46M |
March 25, 2024 | 186.65M |
March 22, 2024 | 225.91M |
March 21, 2024 | 170.28M |
March 20, 2024 | 170.28M |
March 19, 2024 | 159.38M |
March 18, 2024 | 162.65M |
March 15, 2024 | 134.29M |
March 14, 2024 | 118.47M |
March 13, 2024 | 122.84M |
March 12, 2024 | 120.11M |
March 11, 2024 | 125.56M |
March 08, 2024 | 134.29M |
March 07, 2024 | 127.74M |
March 06, 2024 | 123.38M |
March 05, 2024 | 119.02M |
March 04, 2024 | 126.11M |
March 01, 2024 | 133.74M |
February 29, 2024 | 132.11M |
February 28, 2024 | 137.02M |
February 27, 2024 | 141.38M |
February 26, 2024 | 137.02M |
February 23, 2024 | 138.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
118.47M
Minimum
Mar 14 2024
9.084B
Maximum
May 16 2019
1.578B
Average
1.085B
Median
Dec 31 2021
Enterprise Value Benchmarks
Tilray Brands Inc | 1.854B |
Clever Leaves Holdings Inc | -2.630M |
Flora Growth Corp | 15.64M |
InMed Pharmaceuticals Inc | -8.069M |
Lucy Scientific Discovery Inc | 2.371M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -18.00M |
Revenue (Quarterly) | 47.32M |
Total Expenses (Quarterly) | 63.72M |
EPS Diluted (Quarterly) | -0.3673 |
Gross Profit Margin (Quarterly) | 30.74% |
Profit Margin (Quarterly) | -38.03% |
Earnings Yield | -36.73% |
Normalized Earnings Yield | -34.47 |